← Back to Clinical Trials
Recruiting NCT07069478

NCT07069478 Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07069478
Status Recruiting
Phase
Sponsor University of Minnesota
Condition CBD
Study Type INTERVENTIONAL
Enrollment 125 participants
Start Date 2025-06-01
Primary Completion 2026-11-30

Trial Parameters

Condition CBD
Sponsor University of Minnesota
Study Type INTERVENTIONAL
Phase N/A
Enrollment 125
Sex ALL
Min Age 21 Years
Max Age 70 Years
Start Date 2025-06-01
Completion 2026-11-30
Interventions
Stress Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this study is to determine the effects of regular cannabidiol (CBD) use on the psychobiological mechanisms of the stress response. This will be achieved by comparing acute stress responses of adults who either use or do not use CBD regularly. Correlates of CBD use, including tobacco use, will be collected.

Eligibility Criteria

Inclusion Criteria: * Adults who are relatively healthy and aged 21-70 years. * Must keep a normal sleep schedule (sleep during nighttime, awake during daytime). * Must either (1) use CBD daily/regularly or (2) not use CBD regularly. Exclusion Criteria: * Participated in previous acute stress studies that included a similar stress induction. * Current, unstable: major psychiatric disorder or medical condition (e.g., uncontrolled hypertension above 160/100). * Self-reported current pregnancy. * Self-reported current use of illicit substances (other than cannabis). * Non-compliance with instructions for study visit (abstinence from alcohol, caffeine, physical activity, etc.) * Students of the principal researcher

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology